A164V (p.Ala164Val) variant of ATP6V0A4 (Q9HBG4)

A164V (p.Ala164Val) in ATP6V0A4 (Q9HBG4) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes population frequency data and structural context.

A164V (p.Ala164Val) variant details